Search our website

Media Mentions

Developing Vaccine to Prevent Birth Defects from Cytomegalovirus
September 12th, 2017
With eyes on Glaxo’s Engerix-B vaccine, VBI takes hep B candidate into phase 3
July 18th, 2017
Jeff Baxter Interviewed by Equities.com at the Small-Cap Stars Conference
January 12th, 2015
Variation Bio Garners $250K New Funding
September 12th, 2013
VBI Vaccines Pulls in $2.2M Debt Round
February 13th, 2012
VBI Acquires Epixis for VLP Vaccines Capabilities
September 15th, 2011
VBI buys Epixis, Gains CMV, Hep C Vaccines
September 15th, 2011
Variation Biotech Taps Backers for $7.8M in Debt Funding
July 19th, 2011
VBI Progressing with Vaccines That Don’t Require Refrigeration
March 24th, 2011

Sign-up for Our Distribution List to Receive the Latest News and Updates from VBI

Sign Up NowArrow
Go top